We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
-8.85%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.16B
AUM Growth
-$246M
(-17%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-9.27%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
205
New
58
Increased
35
Reduced
52
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$22.3M |
| 2 |
Vontier
VNT
|
+$21.7M |
| 3 |
SS&C Technologies
SSNC
|
+$21.3M |
| 4 |
IPG Photonics
IPGP
|
+$21.3M |
| 5 |
Booking.com
BKNG
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$17.9M |
| 2 |
IS
ironSource Ltd.
IS
|
+$17.2M |
| 3 |
Reinsurance Group of America
RGA
|
+$16M |
| 4 |
VMW
VMware, Inc
VMW
|
+$15.3M |
| 5 |
Belden
BDC
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.14% |
| 2 | Consumer Discretionary | 16.46% |
| 3 | Communication Services | 11.87% |
| 4 | Industrials | 9.35% |
| 5 | Healthcare | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
TD Synnex
SNX
$20.3B
| $3.13M | 0.27% |
+38,566
| New | +$3.68M |
|
102
F5
FFIV
$23.2B
| $3.03M | 0.26% |
+20,907
| New | +$3.31M |
|
103
Orthofix Medical
OFIX
$418M
| $2.93M | 0.25% |
153,477
+990
| +0.6% | +$22.3K |
|
|
EHAB
104
DELISTED
Enhabit
EHAB
| $2.86M | 0.25% |
+203,440
| New | +$3.3M |
|
105
Cognyte Software
CGNT
$689M
| $2.85M | 0.24% |
704,217
+169,603
| +32% | +$804K |
|
106
Johnson Outdoors
JOUT
$501M
| $2.67M | 0.23% |
52,001
-1,468
| -3% | -$91.8K |
|
107
Douglas Emmett
DEI
$1.93B
| $2.61M | 0.22% |
+145,455
| New | +$3.1M |
|
108
Manchester United
MANU
$3.74B
| $2.52M | 0.22% |
189,913
+104,912
| +123% | +$1.31M |
|
109
Progress Software
PRGS
$1.78B
| $2.49M | 0.21% |
+58,575
| New | +$2.71M |
|
110
Mirion Technologies
MIR
$3.75B
| $2.45M | 0.21% |
+328,310
| New | +$2.31M |
|
111
Ziff Davis
ZD
$2B
| $2.37M | 0.2% |
34,658
-988
| -3% | -$77.8K |
|
112
LiveRamp
RAMP
$2.3B
| $2.36M | 0.2% |
+129,901
| New | +$3M |
|
113
Liberty Latin America Class C
LILAK
$1.65B
| $2.29M | 0.2% |
408,956
-1,438,985
| -78% | -$9.26M |
|
114
UNIFI
UFI
$129M
| $2.23M | 0.19% |
+234,862
| New | +$2.93M |
|
|
CIR
115
DELISTED
CIRCOR International, Inc
CIR
| $2.23M | 0.19% |
135,265
-3,839
| -3% | -$63.8K |
|
116
Elanco Animal Health
ELAN
$11.1B
| $2.21M | 0.19% |
+178,343
| New | +$3.12M |
|
117
O-I Glass
OI
$1.08B
| $2.19M | 0.19% |
+169,190
| New | +$2.29M |
|
118
Century Communities
CCS
$1.96B
| $2.18M | 0.19% |
50,978
-1,451
| -3% | -$70.3K |
|
119
Travelzoo
TZOO
$73.9M
| $2.17M | 0.19% |
489,616
-13,965
| -3% | -$81.7K |
|
120
Kilroy Realty
KRC
$4.32B
| $2.06M | 0.18% |
+48,845
| New | +$2.46M |
|
|
VMEO
121
DELISTED
Vimeo
VMEO
| $1.97M | 0.17% |
+492,605
| New | +$2.91M |
|
|
FONR
122
DELISTED
Fonar
FONR
| $1.91M | 0.16% |
135,140
+68,950
| +104% | +$1.01M |
|
123
El Pollo Loco
LOCO
$463M
| $1.82M | 0.16% |
+204,037
| New | +$1.92M |
|
124
BorgWarner
BWA
$14.1B
| $1.82M | 0.16% |
+65,745
| New | +$2.12M |
|
125
Hurco Companies Inc
HURC
$141M
| $1.81M | 0.16% |
80,720
+26,454
| +49% | +$648K |
|
Similar funds
SIG
ORCP
ET
GC
MIAS
TAL
IIP
WCMNY
Invenomic Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Invenomic Capital Management held 205 positions worth $1.16B, down 17% from $1.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Invenomic Capital Management withdrew a net $108M in Q3 2022, closing 59 positions and reducing 52 holdings. Its most notable exit was Cardinal Health, an estimated $17.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Invenomic Capital Management opened a new position in Zoom worth $17.2M.
- Invenomic Capital Management's largest Q3 2022 buy was Zoom: 234,351 shares worth $17.2M.
- Invenomic Capital Management added most to IPG Photonics in Q3 2022, an estimated $21.3M increase.
- Invenomic Capital Management's biggest Q3 2022 reduction was Belden, cutting an estimated $13.5M.
- Invenomic Capital Management fully exited Cardinal Health in Q3 2022, selling an estimated $17.9M.
- Invenomic Capital Management's ten largest holdings make up 23% of its $1.16B portfolio in Q3 2022.
- Invenomic Capital Management opened 58 new positions and closed 59 in Q3 2022.
- Invenomic Capital Management's portfolio value fell 17% quarter-over-quarter to $1.16B.
Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.